Lakeshore Biopharma (NASDAQ:LSB) Trading 1.9% Higher – What’s Next?

Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB) shot up 1.9% during mid-day trading on Friday . The stock traded as high as $2.70 and last traded at $2.62. 4,313 shares traded hands during mid-day trading, a decline of 79% from the average session volume of 20,171 shares. The stock had previously closed at $2.57.

Lakeshore Biopharma Stock Performance

The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.87 and a current ratio of 1.13. The firm has a 50 day moving average price of $4.22.

Institutional Investors Weigh In On Lakeshore Biopharma

Several large investors have recently bought and sold shares of LSB. Barclays PLC purchased a new stake in shares of Lakeshore Biopharma during the third quarter worth $169,000. FMR LLC acquired a new position in Lakeshore Biopharma during the third quarter worth about $803,000. Finally, Hhlr Advisors LTD. acquired a new position in Lakeshore Biopharma during the third quarter worth about $513,000. 52.64% of the stock is currently owned by hedge funds and other institutional investors.

Lakeshore Biopharma Company Profile

LakeShore Biopharma Co, Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.